explore -WSS

explore

author：comprehensive 2025-09-29 14:00:15 - browse：485

foreign-trained health professionals — Adobe

The pharmaceutical industry has been up in arms over Medicare’s first list of 10 prescription drugs that will be subject to negotiations. But other major parts of the health care industry — hospitals, doctors, and other providers — have refrained from either lending support or criticizing the government’s process.

The American Hospital Association, the industry’s main lobbying group, told STAT it is “not commenting on this issue right now.” The American Medical Association had no comment and deferred to other physician trade groups. The Federation of American Hospitals offered no statement.

The American Health Care Association, which lobbies on behalf of nursing homes, did not comment on the list of 10 drugs or Medicare’s negotiating power. But it said in a statement that “many nursing home residents have multiple chronic conditions that require several medications, so any efforts at reducing their out-of-pocket costs would be welcome.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Medicare Advantage overpayments discussion gets experts fired up

Wikipedia

WSS

STAT letters to the editor on burnt

Why sickle cell disease is getting the first CRISPR treatment

Sanofi says it has 12 blockbusters on the way. Will investors believe it?

American taxpayers paid $1.8 trillion in health care costs in 2022

Rune Labs, whose app tracks Parkinson's symptoms, raises $12M

A preacher's new calling: Diversifying neuroscience research

hotspot

explore

entertainment

Wildfire smoke exposes gaps in outdoor worker protections

JPM pitch from hospitals? Revenue streams outside of patient care

As demand for Covid shots wanes, Moderna seeks its next success

Fauci's latest grilling in Congress: 9 hours, behind closed doors

Guidelines to prevent youth baseball injuries need more muscle

Boston Scientific acquires urology company Axonics for $3.7 billion

New air purifier tech could be key to improving indoor air quality

Study suggests new cause of Down syndrome: cells linked to aging

Jerome Adams on the need for new antivirals for Covid

AbbVie buys Immunogen, maker of targeted cancer drugs, for $10B

explore

Leukemia patients are helped by Syndax's new type of therapy

Boston Scientific acquires urology company Axonics for $3.7 billion

Fauci's latest grilling in Congress: 9 hours, behind closed doors

CMS should re

What PEPFAR has meant on the ground in Ukraine

FDA needs staff influx to meet gene therapy needs, Marks says

explore

focus

Wikipedia

leisure time